Seminal fluid values of the 20 patients treated with mDRV/C compared with the results of 21 patients treated initially with ART and then with mDRV/r [6].

<p>Seminal fluid values of the 20 patients treated with mDRV/C compared with the results of 21 patients treated initially with ART and then with mDRV/r [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0196257#pone.0196257.ref006" target="_blank">6</a>].</p

Baseline patients’ characteristics.

<p>Baseline patients’ characteristics.</p

Kaplan-Meier estimations of the efficacy as determined by on-treatment analysis applying different criteria for virological failure.

<p>Kaplan-Meier estimations of the efficacy as determined by on-treatment analysis applying different criteria for virological failure.</p

Percentages of detectable HIV-RNA determinations (red) according to virological behavior during the follow-up for ritonavir-boosted protease inhibitor monotherapy.

<p>Undetectable viremia (green).</p